BioSpace News Archive

Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced the acceptance of two scientific abstracts at the PAINWeek® 2020 National Conference which will take place virtually September 11-13, 2020 . Details of the poster presentations are as follows:

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic

Computer, phone, and tablet screens have been life-savers for millions who are managing work and home activities through our new socially-distanced reality during the COVID-19 pandemic.

Selexis SA and Igyxos announced today that they have entered into a service agreement to develop Igyxos’ first-in-class monoclonal antibody (mAb) drug candidate for the treatment of human infertility.

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical-stage biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that it has submitted an Investigational New Drug application (IND) to the U.S. Food and Drug Administration (FDA) for a planned Phase 2b clinical trial in locally advanced, inoperable

CV Sciences, Inc., a preeminent leader in hemp-derived cannabidiol products, is pleased to announce the launch of its new corporate website, reflecting the Company’s refreshed brand positioning, core values and mission.

Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into a COVID-19 testing and contract partnership with Pangea, based in Israel

Dow has been named as one of the 2020 PEOPLE’s “50 Companies that Care” by Great Place to Work® and PEOPLE.

Prime Therapeutics LLC (Prime) is rolling out Real Time Benefit Check starting with myBenefitCheck from health care technology pioneer DrFirst, giving health care providers comprehensive information so they can easily prescribe the most appropriate and cost-effective medications at the point of care.

PharmAbcine (KRX: 208340ks), a biotech company focusing on the development of antibody therapeutics, announced on August 31 that it had signed a contract manufacturing organization(CMO) agreement with Binex, a leading biologics CDMO(Contract Development and Manufacturing Organization) company in Korea.